Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: A meta-analysis

Liver Transplantation

Volumn 10, Issue 9, 2004, Pages 1099-1106

  Khuroo, Mohammed S ^a,c   Khuroo, Mehnaaz S ^b   Farahat, Karim L C ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b SRI RAMACHANDRA UNIVERSITY   (India)

^c NONE   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

DIGESTIVE TRACT AGENT;

ALBUMIN DIALYSIS; ANEMIA; BIBLIOGRAPHIC DATABASE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; COCHRANE LIBRARY; CONVALESCENCE; DIALYSIS; EMBASE; ENTEROHEPATIC CIRCULATION; FEVER; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDLINE; META ANALYSIS; METHODOLOGY; MORTALITY; PATIENT SELECTION; PEER REVIEW; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAMPLE SIZE; SENSITIVITY ANALYSIS; SIDE EFFECT; SURVIVAL; TIME; TREATMENT OUTCOME;

CHRONIC DISEASE; HUMANS; LIVER FAILURE; LIVER FAILURE, ACUTE; LIVER, ARTIFICIAL; RANDOMIZED CONTROLLED TRIALS; SELECTION BIAS; SORPTION DETOXIFICATION; SURVIVAL ANALYSIS;

EID: 4544266358     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20139     Document Type: Review

References (31)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F eds. Progress in Liver Failure. New York: Gruen and Stratton, 1970:292-298.
2. Lee WM. Acute liver failure. N Engl J Med 1993;329:1862-1872.
3. Fontana R. Acute liver failure. Current Opinion in Gastroenterology 1998;14:265-273.
4. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995;21: 24O-252.
5. Jalan R, Williams R. Acute on chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002;20:252-261.
6. Rahman TM, Hodgson HJ. Review article: Liver support systems in acute hepatic failure. Aliment Pharmacol Ther 1999;13: 1255-1272.
7. Rajvanshi P, Larson AM, Kowdley K. Temporary support for acute liver failure. J Clin Gastroenterol 2002;35(4):335-344.
8. Allen JW, Hassanein, Bhatia SN. Advances in bioartificial liver devices. Hepatology 2001;34:447-455.
9. Liu JP, Kjaegard LL, Als-Neilsen B, Gluud C. Artifical and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group protocol. Liver 2002;22:433-438.
10. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartifical support systems for acute and acute-on-chronic live failure. A systemic review. JAMA 2003; 289:217-222.
11. Mitzner SR, Stange J, Klammt S. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001;12:S75-S82.
12. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R. Albumin dialysis using the molecular adsorbent recirculating system. Curr Opin in Nephrol and Hypertens 2001;10:777-783.
13. Moher D, Cook DJ, Eastwood S, Olkin I, Rennei D, Stroup DF. Improving the quality of reports of meta-analysis of randomized controlled trials: the QUOROM statement. Lancet 1999;354: 1896-1900.
14. Petitti DB. Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis. 2nd ed. New York: Oxford University Press; 2000.
15. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-1060.
16. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
17. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315: 629-634.
18. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867-872.
19. Cucherat M, Boissel JP, Leizorovicz A. EasyMA: a program for the meta-analysis of clinical trials. Computer Methods and Programs in Biomedicine 1997;53:187-190.
20. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000;6(3):277-286.
21. Heeman U, Trechel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 6:949-958.
22. El-Banayosy A, Kizner L, Noto M, Cobaugh D, Schueler V, Bergmeier S, Koerfer R. Evaluation of MARS technique on patients suffering from hypoxic liver failure following cardiogenic shock. Proceedings of the 4th International symposium on albumin dialysis in liver disease; September 6-8, 2002; Rostock-Warnemünde, Germany.
23. Schmidt LE, Wang LP, Hansen BA, Larsen FT. Systemic hemodynamic effects of treatment with the molecular adsorbent recirculating system inpatients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 2003;9:290-297.
24. Hessel FP, Mitzner SR, Guellsorff B, Wasem J. Economic evaluation and i-year survival analysis of MARS in patients with alcoholic liver disease. Liver Int 2003;23:66-72.
25. Chen S, Zhang L, Yang X, Wang M. Molecular adsorbent recirculating system: clinical experience in patients with liver failure based in hepatitis B in china. Liver 2002;22:48-51.
26. Mullen KD: Treatment of hepatorenal syndrome: lessons from the MARS trial. Hepatology 2002;35(2):492-493.
27. Schmidt LE, Svendsen LB, Sorensen VR, Hansen BA, Larsen FS. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure. Liver Transpl 2001;7:709-712.
28. Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS registry. Liver 2002;22(2):20-25.
29. Stange J, Hassanei T, Mehta R, Mitzner R, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002;26:103-110.
30. Steiner C, Zinggrebe A, Viertler A. Experiences with MARS therapy in liver disease: analysis of 385 patients of the international MARS registry. Abstract 174. Proceedings of the 54th Annual Meeting of the American Association for the Study of Liver Diseases; October 24-28, 2003; Boston, Mass.
31. Kunz R, Vist G, Oxman AD. Randomization to protect against selection bias in healthcare trials to protect against selection bias in healthcare trials (Cochrane Review on CD-ROM). Oxford, England: Cochrane Library, Update Software; 2002; issue 4.